Authors:
Sugiyama, Y
Kato, M
Chen, FA
Williams, SS
Kawaguchi, Y
Miya, K
Jong, YS
Mathiowitz, E
Egilmez, NK
Bankert, RB
Citation: Y. Sugiyama et al., Human inflammatory cells within the tumor microenvironment of lung tumor xenografts mediate tumor growth suppression in situ that depends on and is augmented by interleukin-12, J IMMUNOTH, 24(1), 2001, pp. 37-45
Citation: H. Kusuhara et Y. Sugiyama, Efflux transport systems for drugs at the blood-brain barrier and blood-cerebrospinal fluid barrier (Part 2), DRUG DISC T, 6(4), 2001, pp. 206-212
Citation: H. Kusuhara et Y. Sugiyama, Efflux transport systems for drugs at the blood-brain barrier and blood-cerebrospinal fluid barrier (Part 1), DRUG DISC T, 6(3), 2001, pp. 150-156
Authors:
Yamanaka, T
Horikoshi, Y
Suzuki, A
Sugiyama, Y
Kitamura, K
Maniwa, R
Nagai, Y
Yamashita, A
Hirose, T
Ishikawa, H
Ohno, S
Citation: T. Yamanaka et al., PAR-6 regulates aPKC activity in a novel way and mediates cell-cell contact-induced formation of the epithelial junctional complex, GENES CELLS, 6(8), 2001, pp. 721-731
Citation: K. Tohgo et al., Ply-cracking damage theory for cross-ply laminate and its application to finite element method, JSME A, 44(2), 2001, pp. 282-290
Authors:
Oshikawa, K
Kuroiwa, K
Tago, K
Iwahana, H
Yanagisawa, K
Ohno, S
Tominaga, SI
Sugiyama, Y
Citation: K. Oshikawa et al., Elevated soluble ST2 protein levels in sera of patients with asthma with an acute exacerbation, AM J R CRIT, 164(2), 2001, pp. 277-281
Authors:
Oshikawa, K
Kuroiwa, K
Tokunaga, T
Kato, T
Hagihara, SI
Tominaga, SI
Sugiyama, Y
Citation: K. Oshikawa et al., Acute eosinophilic pneumonia with increased soluble ST2 in serum and bronchoalveolar lavage fluid, RESP MED, 95(6), 2001, pp. 532-533
Authors:
Mizushina, Y
Sugiyama, Y
Yoshida, H
Hanashima, S
Yamazaki, T
Kamisuki, S
Ohta, K
Takemura, M
Yamaguchi, T
Matsukage, A
Yoshida, S
Saneyoshi, M
Sugawara, F
Sakagauchi, K
Citation: Y. Mizushina et al., Galactosyldiacylglycerol, a mammalian DNA polymerase alpha-specific inhibitor from a sea alga, Petalonia bingbamiae, BIOL PHAR B, 24(9), 2001, pp. 982-987
Authors:
Shirota, K
Kato, Y
Irimura, T
Kondo, H
Sugiyama, Y
Citation: K. Shirota et al., Anti-metastatic effect of the sialyl Lewis-X analog GSC-150 on the human colon carcinoma derived cell line KM12-HX in the mouse, BIOL PHAR B, 24(3), 2001, pp. 316-319
Citation: S. Ohmori et al., A protective effect against undesirable increase of dihydroetorphine permeation through damaged skin by using pressure-sensitive adhesive tape with an ethylene-vinyl acetate co-polymer membrane, BIOL PHAR B, 24(1), 2001, pp. 78-83
Citation: Y. Sugiyama et T. Kumagai, Chemical characterization of organic carbon dissolved in natural waters using inorganic adsorbents, ANAL SCI, 17(1), 2001, pp. 77-82
Authors:
Matsuo, A
Watanabe, A
Takahashi, T
Futamura, M
Mori, S
Sugiyama, Y
Takahashi, Y
Saji, S
Citation: A. Matsuo et al., A simple method for classification of cell death by use of thin layer collagen gel for the detection of apoptosis and/or necrosis after cancer chemotherapy, JPN J CANC, 92(7), 2001, pp. 813-819
Authors:
Kawaguchi, J
Kii, I
Sugiyama, Y
Takeshita, S
Kudo, A
Citation: J. Kawaguchi et al., The transition of cadherin expression in osteoblast differentiation from mesenchymal cells: Consistent expression of cadherin-11 in osteoblast lineage, J BONE MIN, 16(2), 2001, pp. 260-269
Authors:
Tsukamoto, Y
Kato, Y
Ura, M
Horii, I
Ishitsuka, H
Kusuhara, H
Sugiyama, Y
Citation: Y. Tsukamoto et al., A physiologically based pharmacokinetic analysis of capecitabine, a tripleprodrug of 5-FU, in humans: The mechanism for tumor-selective accumulationof 5-FU, PHARM RES, 18(8), 2001, pp. 1190-1202
Authors:
Mizuno, N
Kato, Y
Iwamoto, M
Urae, A
Amamoto, T
Niwa, T
Sugiyama, Y
Citation: N. Mizuno et al., Kinetic analysis of the disposition of insulin-like growth factor 1 in healthy volunteers, PHARM RES, 18(8), 2001, pp. 1203-1209
Authors:
Nishiyama, N
Kato, Y
Sugiyama, Y
Kataoka, K
Citation: N. Nishiyama et al., Cisplatin-loaded polymer-metal complex micelle with time-modulated decaying property as a novel drug delivery system, PHARM RES, 18(7), 2001, pp. 1035-1041
Authors:
Han, YH
Kato, Y
Haramura, M
Ohta, M
Matsuoka, H
Sugiyama, Y
Citation: Yh. Han et al., Physicochemical parameters responsible for the affinity of methotrexate analogs for rat canalicular multispecific organic anion transporter (cMOAT/MRP2), PHARM RES, 18(5), 2001, pp. 579-586
Authors:
Ishigam, M
Uchiyama, M
Kondo, T
Iwabuchi, H
Inoue, S
Takasaki, W
Ikeda, T
Komai, T
Ito, K
Sugiyama, Y
Citation: M. Ishigam et al., Inhibition of in vitro metabolism of simvastatin by itraconazole in humansand prediction of in vivo drug-drug interactions, PHARM RES, 18(5), 2001, pp. 622-631
Authors:
Okudaira, N
Fujigaki, M
Nakayoshi, T
Komiya, I
Sugiyama, Y
Citation: N. Okudaira et al., Up-regulation of carnitine transporters helps maintain tissue carnitine levels in carnitine deficiency induced by pivalic acid, PHARM RES, 18(4), 2001, pp. 439-445
Authors:
Sugano, M
Conway, TF
Kelleher, RJ
Sugiyama, Y
Chen, FA
Bankert, RB
Bernstein, SH
Citation: M. Sugano et al., Human dendritic cells pulsed with autologous Epstein-Barr virus transformed B-cell lymphoblastoid cell (BCL) lysate elicit a BCL specific MHC-Class II restricted T-cell response, J EXP CL C, 20(2), 2001, pp. 175-182